BIOS Health news includes the SPARC-NIH Neuromod Prize award, a PwC Strategy& Insider Podcast, a Nature feature on nervous-system data insights, and a partnership with a UK heart and lung hospital on chronic cardiorespiratory disease risk factors.
The company aims to improve quality of life through neural engineering and brings together people from neuroscience, machine learning and AI, hardware and software engineering, medicine, operations, finance, business development, and communications.
BIOS was co-founded by Cambridge University graduates Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer. Its team spans neuroscience, machine learning, engineering, biotechnology, and medicine.
BIOS Health uses AI-powered neural interfaces to automatically read and write neural signals, initially targeting cardiac conditions. It aims to develop data-driven digital health treatments for chronic disease and precision medicine.